![](/img/cover-not-exists.png)
Blood transcriptomic signatures of Alzheimer's patients treated with a novel Alzheimer's disease drug, EHT 0202, allow identification of novel potential biomarkers correlated with treatment response and efficacy
Desire, Laurent, Carriere, Jennyfer, Blondiaux, Elodie, Lemarie, Jean-Christophe, Einstein, Rich, Beurdeley, Pascale, Pando, MattVolume:
7
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2011.09.035
Date:
July, 2011
File:
PDF, 53 KB
english, 2011